Introduction
Wilms' tumor is a childhood kidney cancer derived from metanephric blastemal cells. It is usually diagnosed in the ®rst 5 years of life. At the time of resection, these tumors express IGF2 at levels characteristic of fetal tissues, which are much higher than those found in the surrounding normal kidney (Reeve et al., 1985; Scott et al., 1985) . This overexpression may, at least in part, be related to disruption of the parental genomic imprinting of the IGF2 gene.
The term parental imprinting refers to the differential behavior of the two copies of a gene depending on the sex of the parent from which each was transmitted. IGF2, one of the few mammalian genes known to be imprinted, is normally expressed exclusively from the paternal copy in the mouse (DeChiara et al., 1991) and human (Giannoukakis et al., 1993) . Interestingly Igf2r, the murine gene encoding one of the two receptors to which IGF-II binds, is also imprinted, but with exclusive maternal expression (Barlow et al., 1991) . Thus IGF2 is reversibly inactivated upon passage from the maternal germline, while Igf2r is inactivated upon passage from the paternal one.
The presence, in opposite parental sexes, of this unusual property in two genetically unlinked but functionally coupled genes may be related to opposing eects of Igf2 and Igf2r expression on fetal growth (Haig and Graham, 1991) . It is known that the mitogenic actions of IGF-II are transmitted by the type I IGF receptor (Kiess et al., 1987; Ellis et al., 1996) , which binds both IGF-I and IGF-II and acts as a ligand-activated tyrosine kinase. By contrast, IGF2R encodes a 280 kDa membrane receptor with no known intracellular transduction mechanism, involved in the targeting of lysosomal enzymes to the lysosomes (reviewed by Polychronakos, 1989) . In addition to its mannose 6-phosphate binding site through which it recognizes the unique glycosylation pattern of lysosomal enzymes, this receptor has a high-anity speci®c IGF-II binding site, involved in the targeting of IGF-II for rapid lysosomal degradation (Oka et al., 1985; Ellis et al., 1996) . This may explain the lower mitogenic potency of IGF-II in most biologic systems, although it binds to the type I receptor with anity equal to that of IGF-I (Germain- Lee et al., 1992) . It may also be related to a tumor suppressor function of IGF2R (De Souza et al., 1995a,b; Hankins et al., 1996) .
It is not known whether the postnatal persistence of the high fetal levels of IGF2 expression is of etiologic signi®cance in Wilms' tumor, or merely a marker of its embryonal nature. In favor of a causative role is the recent discovery of three completely independent molecular pathologies, all with the potential to increase IGF2 expression, and all occurring with high frequency in Wilms' tumors: (1) Paternal disomy of 11p15.5, that would result in expression of IGF2 from two instead of one gene copy, is sometimes seen in Wilms' tumors (Slater and Mannens, 1992) and the Beckwith-Wiedemann syndrome (Henry et al., 1991) , a condition that predisposes to Wilms' tumors. (2) Twothirds of Wilms' tumors maintaining heterozygosity at the IGF2 locus show relaxation of imprinting (Rainier et al., 1993; Ogawa et al., 1993a) , allowing expression of both copies, and this is also seen constitutionally in the Beckwith-Wiedemann syndrome (Weksberg et al., 1993) . (3) The WT1 gene, whose inactivation accounts for some Wilms' tumors, encodes a zinc-®nger protein that, in vitro, represses expression of IGF-II (Drummond et al., 1992) and of its mitogenic receptor (Werner et al., 1993) . The diversity of the molecular abnormalities that can cause increased IGF2 dosage in Wilms' tumor makes it unlikely that it is a mere embryonal marker.
Through the role of its protein product in IGF-II degradation, IGF2R is involved in regulating IGF-II availability to the cell. Unlike its murine homologue, human IGF2R is expressed from both gene copies (Ogawa et al., 1993b; Kalscheuer et al., 1993) , with the exception of some individuals that were found to exclusively express the maternal allele only (Xu et al., 1993; Smrzka et al., 1995) . In the human, the parentof-origin speci®c methylation believed to underlie imprinted Igf2r expression in the mouse (StoÈ ger et al., 1993) also exists (Smrzka et al., 1995; Riesevijk et al., 1996) , although it causes imprinted expression only in a small proportion of subjects. This phylogenic conservation of IGF2R imprinting in some humans might result in decreased inactivation of IGF-II through a gene dosage eect, and thus mimic IGF2 overexpression. To test the potential signi®cance of this in tumorigenesis, we examined the occurrence and frequency of IGF2R imprinting in Wilms' tumors and the corresponding normal kidney. We report that in the kidneys of 50% of Wilms tumor patients there is partial repression of the paternal IGF2R copy, which seems to constitute an aberrant persistence of a fetal feature in a postnatal tissue.
Results

IGF2R imprinting in tumor and surrounding normal kidney tissue
Transcripts from each IGF2R copy were distinguished using two transcribed CA repeat polymorphisms, both in the 3' untranslated region. Of the 37 patients examined, 16 were heterozygous and in 15 parental origin could be assigned from informative parental DNA.
In all cases, both alleles could be seen in the RT ± PCR product from tumor and normal kidney. However, one allele was markedly less intense than the other in eight of 16 cases, suggesting the possibility of partial imprinting. Parental DNA was informative in seven of the eight cases and when parental origin was determined, in each case the weaker allele was paternal (one-tailed P=0.016 against a binomial distribution), indicating a parent-of-origin eect analogous to that seen in the mouse (Barlow et al., 1991) and in a few human subjects (Xu et al., 1993 , Smrzka et al., 1995 .
In order to con®rm our visual impression, we quanti®ed the intensity of each band by densitometric video scanning. The results are shown in Figure 1 . Twenty-two samples of DNA from normal fetal tissues were used as technical controls in which any discrepancy in the intensity of the two alleles can be safely attributed to technical error. The ratio of the weaker over the stronger of the two alleles is shown in Figure 1a as a frequency histogram of the values obtained. Most ratios clustered close to 1, and all were over 0.66, which we considered the outer limit of allele discrepancy due to technical variation. The same pattern was seen in the DNA from the Wilms tumors and corresponding normal kidney.
RT ± PCR product from Wilms tumors and corresponding normal kidney tissue showed a dramatically dierent pattern, with the allele ratio in half the samples being much less than 0.66 (Figure 1b) . Of the two frequency peaks, one was indistinguishable from Figure 1 Frequency histograms of the intensity ratios of the weaker over the stronger IGF2R allele. Radiolabeled PCR (or RT ± PCR) products were separated by electrophoresis, visualised by autoradiography, and the autoradiograms quanti®ed by densitometric video scanning. that in the DNA, and the other clustered around 0.3, with virtually no overlap. The weaker allele in the lower cluster was always paternal, while in the cluster that was similar to genomic DNA (technical variation) there was no parental eect. On this basis, we divided tissue samples as`imprintor' (eight subjects) or`nonimprintor' (eight subjects, example shown in Figure  2a ). In 7/8 imprinting cases, the pattern was the same in tumor and in normal kidney tissue (Figure 2b ). In the eighth case, imprinting was seen only in the tumor (Figure 2c ). To con®rm that the dierence between alleles seen in the PCR product re¯ects relative abundance in the template in a linear fashion, the following experiment was performed: cDNA from two individuals, each homozygote for a dierent allele was mixed in a range of proportions (Figure 3 ). There is a linear change in the relative density of each ampli®ed allele according to its proportion in the mixed cDNA template.
The frequency of IGF2R imprinting in Wilms' tumor is same as in normal fetal kidney
To determine the possible signi®cance of partial repression of the paternal allele in the kidneys of 50% of Wilms' tumor patients, we ®rst examined this phenomenon in normal human fetal kidney. Of 11 informative fetal kidney samples, ®ve showed partial repression of one allele in a pattern similar to that seen in Wilms' tumor (Figures 1c and 4a ). Parental origin of the repressed allele could not be determined as parental DNA was not available. Assuming paternal origin, the frequency of partial IGF2R imprinting in Wilms' tumor appears to be the same as in normal fetal kidney.
Aberrant persistence of IGF2R imprinting in Wilms' tumor
A more meaningful comparison to Wilms' tumor patients would have required normal postnatal juvenile kidney tissue, which was not available for ethical reasons. IGF2R imprinting may be lost postnatally in normal individuals, in which case its persistence in the kidneys of Wilms tumor patients may be a fetal feature which might play a causative role in tumorigenesis. Indeed, in the Igf2r knockout model, the few mice that survive disruption of the maternal allele show perinatal reactivation of the paternal allele, which is silenced in utero (Wang et al., 1994) . A similar phenomenon in the human was suggested by our preliminary observations of partial or complete repression of the paternal IGF2R allele in mid-gestation but not in term placenta (Xu et al., 1993) . To further test the possibility of such developmental loss of imprinting, pre-term placenta (7 ± 20 weeks of fetal age) and term placenta (38 ± 41 weeks of gestation) were compared. Five out of 12 pre-term placentae showed clearly dierential expression of the two alleles (allele intensity ratios 50.6, Figure 1c ) the repressed allele being the paternal one in all four informative cases. In all 12 term placentae, on the other hand, the two alleles were expressed at nearly equal levels (Figures 1e and 4c ). This result (two sided P=0.037 by the Fisher exact test) suggests that IGF2R imprinting in placenta is turned o by the time of birth.
Next, we addressed the question of whether this developmental reactivation of the partially repressed paternal IGF2R seen in placenta re¯ects a similar process in other organs. In six fetuses aged 12 ± 18 weeks the ratios of allele expression level in various tissues, including kidney, ranged from 0.01 to 0.98 (gels Equal amount of total RNA from two individuals homozygous for two dierent alleles was used in RT and the cDNA was mixed at dierent proportions as indicated. Experimental procedure of the RT ± PCR is the same as in Figure 2 -0:10 -1:9 -2:8 -3:7 -4:6 -5:5 -6:4 -7:3 -8:2 -9:1 -10:0
shown in Xu et al., 1993) . Without exception, the placental ratio closely predicted that seen in every other tissue from the same fetus (correlation coecient of placental ratio to that seen in other tissues=0.94, P50.001). Examples of this lack of tissue speci®city, whereby the degree of IGF2R imprinting (or lack of it) is similar in all tissues in a given subject, is illustrated in Figure 4a and b. In addition, the low frequency of imprinting in term placenta (0/12) is consistent with the very low frequency of imprinting we have previously reported in postnatal white blood cells (2/26, Xu et al., 1993) and found by others in lymphoblastoid lines (1/69, Smrzka et al., 1995) . Therefore, if the developmental turn-o of IGF2R imprinting seen in placenta and white blood cells also applies to kidney, its postnatal persistence in the kidneys of Wilms' tumor patients may be a fetal feature that has etiologic signi®cance.
Evidence for control of IGF2R imprinting by a cisacting locus
Additional analysis of IGF2R imprinting of the two most common alleles (162 and 164 bp) revealed evidence of control of IGF2R imprinting by a cisacting locus: The 162 allele was present in all seven of the imprintors that were informative for parental origin. This allele was the preferentially expressed one, and was of maternal origin in all seven cases (P=0.03). As six of these imprintors were 162/164 heterozygotes, 164 was repressed and of paternal origin in all six. Parental origin of these alleles was random in the eight non-imprinting patients (Table 1 ). This does not appear to be a special feature of Wilms' tumors, as in all three of the four informative normal pre-term placentae that were 162/164 heterozygotes, 164 was maternal and expressed at higher level. This suggests that IGF2R imprinting is determined by a cis-acting locus linked to our marker, probably a sequence variation within the imprinted domain itself. Alleles that make the gene susceptible to paternal-germline inactivation are in linkage disequilibrium with 164 and, probably, rarer alleles other than 162.
Discussion
We have demonstrated a high frequency of IGF2R imprinting in the kidneys of patients with Wilms' tumor (50%). IGF2R had previously been reported not to be imprinted in human fetal and postnatal tissues including kidney (Ogawa et al., 1993b; Kalscheuer et al., 1993) , except in a small proportion of subjects as reported by our group (Xu et al., 1993) and others (Smrzka et al., 1995) . Because it is impossible to obtain normal postnatal kidney, the signi®cance of IGF2R imprinting in Wilms' tumor can only be determined indirectly. Its frequency is compared to and shown to be the same as that seen in the normal fetal kidney. However, the developmental turno of IGF2R imprinting that is suggested by our data to occur sometime between 20 and 40 weeks gestation in placenta, probably re¯ects a similar phenomenon in other tissues including kidney. This is suggested by the very low frequency of imprinting in blood cells found by us (Xu et al., 1993) and in lymphoblastoid cell lines by others (Smrzka et al., 1995) . If such is the case, then the persistence of IGF2R imprinting in the kidneys of Wilms' tumor patients can be seen as the abnormal persistence of an embryonal feature that may predispose to tumor formation. The ®nding of abnormalities reminiscent of embryonic features in both IGF2 and IGF2R, two genetically unlinked but functionally coupled genes, strengthens the case for a causal role of inappropriate IGF2 expression in Wilms' tumor. IGF2R imprinting might act along the same chain of events, through diminished inactivation of the IGF2 product. Our ®nding also suggests that aberrant imprinting is one mechanism by Figure 4 Representative examples of (a) Partial IGF2R imprinting, to a variable extent, in three normal human fetal kidneys, one of them closely correlating with similar imprinting in liver. (b) Further illustration of the lack of tissue speci®city in IGF2R imprinting in the same fetus, where imprinting is absent in all three tissues studied, including kidney. (c) Equal expression of the two IGF2R alleles in term placentae, indicating absence of imprinting after 38 weeks gestation. Numbers represent dierent subjects. Techniques and abbreviations are the same as in Figure 2 IGF2R imprinting in Wilms' tumor Y Xu et al which a tumor suppressor gene may be inactivated. IGF2R has been implicated as a tumor suppressor in hepatocellular carcinoma (De Souza et al., 1995a,b) and breast cancer (Hankins et al., 1996) . Loss of heterozygosity (LOH) in one gene copy and miss-sense mutation in the other have both been demonstrated. In these adult tumors mitotic deletion, manifesting as LOH, seems to be the mechanism of the allelic loss. Similar allelic loss in Wilms' tumor can be due to aberrant persistence of imprinting. The dierence between Wilms' tumor and these tumors may be due to the relative importance of imprinting early in life, compared to the larger number of opportunities for somatic mutation with advancing age in adult tissues. We also present evidence that imprinting in these Wilms' tumor patients shows a genetic association with a locus in cis-. Alleles that make the gene susceptible to paternal-germline inactivation are in linkage disequilibrium with 164 and, probably, rarer alleles other than 162. The absence of repression in the paternal 164 in our non-imprinting patients, as well as normal 164 expression in the majority of unselected normal individuals (Xu et al., 1993; Ogawa et al., 1993b; Kalscheuer et al., 1993) would indicate that the frequency of the`imprintable' allele is much lower than that of 164. Alternatively, permissive cis alleles may be necessary but not sucient, imprinting additionally depending on a trans-locus or non-genetic factors.
The one case where a paternal 164 was repressed in the tumor but not in the normal kidney tissue may be due to mosaicism in the normal kidney, if the tumor arose from one of a small fraction of imprinting cells. This is additional evidence for an etiologic signi®cance of the persinstence of IGF2R imprinting in Wilms' tumor.
The statistically signi®cant association of imprinted expression with speci®c cis-alleles, suggests a ®rst insight into the molecular mechanism of the divergence of IGF2R imprinting between mouse and human. It appears that a sequence variation in or near the human gene can determine whether it is imprinted as in the mouse. Imposition of a gamete-speci®c imprint must involve recognition of a sequence in cis to the imprinted gene, referred to as imprint controlling element (ICE) (Nicholls, 1994) . Recent evidence indicates that ICE mutations in the Angelman and Prader-Willi syndrome loci may result in the presence of a maternal imprint on the paternal chromosome, or vice versa (Reis et al., 1994) . By a similar mechanism, an IGF2R sequence variant might cause the paternal IGF2R copy to behave like the maternal. If so, such a variant in cis to the 164 allele appears to have become the predominant haplotype in Homo Sapiens. On the other hand, the imprinting machinery inactivating the paternal allele in the presence of an imprintable ICE seems to be still operative, probably because it is shared with other imprinted loci. Components of this machinery may also be polymorphic, as suggested by the observation that gamete-speci®c methylation of the same transgene can vary in dierent mouse strains (Allen et al., 1990; Sapienza et al., 1989) , and by the genotype-dependence of the imprinted lethal Tme phenotype (Forejt and Gegorova, 1992) . Thus, additional contribution by trans-acting elements to variation in IGF2R imprinting cannot be ruled out.
Given the evidence of a molecular methylation imprint analogous to that seen in the mouse being present in the human (Smrzka et al., 1995; Riesewijk et al., 1996) , a search for IGF2R sequence dierences between imprintor and non-imprintor individuals is underway in our laboratory to answer the questions arising from these observations.
Materials and methods
Samples
We examined 37 Wilms' tumor patients from the Pediatric Oncology Group tissue bank collected, with informed consent, from various North American centers. IGF2R imprinting was evaluated in tumors and matched normal kidney tissue. As controls, kidney, placenta, and other tissue obtained from aborted normal fetuses (7 ± 20 week of fetal age) and term placenta tissue (38 ± 41 week of gestation) were also examined.
Nucleic acid extraction
Frozen tissues were pulverized under liquid N 2 and DNA and RNA were extracted by phenol-chloroform (Xu et al., 1993) . RNA was subjected to DNase I digestion to remove traces of contaminating genomic DNA.
Imprinting assay
In order to evaluate IGF2R expression from each gene copy we used transcribed CA repeat polymorphisms at the 3' untranslated region (Goto et al., 1992; Xu et al., 1993) . Parental origin of IGF2R mRNA transcripts was evaluated by reverse transcription-PCR ampli®cation (RT ± PCR).
Two CA-rich fragments, both from the 3' untranslated region of IGF2R, were ampli®ed by PCR. Primer sequences are given in references (Goto et al., 1992; Xu et al., 1993) . Thirty cycles of ampli®cation were performed at 948C for 30 s, 608C for 30 s, 728C for 90 s. The PCR product was labeled by the addition of 5 mCi of [ 32 P]-dATP, or by 5' labeling of one primer. Fragments were electrophoresed in 6% polyacrylamide gel (internally labeled fragments) or in an 8M urea denaturing gel following heat denaturation in 50% formamide (end-labeled fragments).
For RT ± PCR we used 5 ± 10 mg of total RNA which was reverse-transcribed using MMLV reverse transcriptase (Superscript, Life Technologies), primed with either the anti-sense PCR primers or random hexamers, which had same result. The absence of contaminating genomic DNA was con®rmed in all samples by running parallel control reactions in which the reverse transcriptase was omitted. These samples invariably gave no visible bands.
Relative quanti®cation of the bands were performed by scanning of the autoradiograms with a video camera, interfaced to densitometry software (Snappy FrameGrabber, Rancho Cordova, CA).
